.After F2G's 1st try to obtain a new lesson of antifungal to market was thwarted by the FDA, the U.K...
.Moderna has actually vowed to reduce R&D costs by $1.1 billion through 2027. The selection to re...
.Just four months after Sanofi bet $80 million in upfront money on Key Therapies' losmapimod, the pl...
.Cancer business Oncternal Rehabs is folding all its medical tests and giving up staff, switching it...
.Roche is actually keeping out hopes that its injectable being overweight possibility can ultimately...
.Novo Nordisk has lifted the cover on a stage 1 test of its dental amylin as well as GLP-1 receptor ...
.Just a few short full weeks after succeeding an FDA Fast Track tag for its investigational BTK degr...
.Not long after a good records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based company ...
.BridgeBio Pharma is actually lowering its own gene therapy budget plan and pulling back from the me...
.GSK's try to build the 1st vaccine for herpes simplex infection (HSV) has ended in breakdown, leavi...